ctrl K

/

Search

Popular

KO Coca Cola Company Stock

TSLA Tesla Inc Stock

AMD Advanced Micro Devices Stock

SPY SPDR S&P 500 ETF Trust ETF

NVDA Nvidia Stock

Watchlist Price Alert

Aditxt Inc. (ADTX)

NASDAQ: ADTX · Real-Time Price · USD

1.72

0.02 (1.18%)

At close: May 09, 2025, 3:42 PM

Insider Trading

Congress Trading

No data available

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

ADTX News

7 days ago - Upcoming Aditxt Weekly Update to Feature Dr. Shahrokh Shabahang, Chief Innovation Officer (CIO) of Aditxt™, and Dr. Friedrich Kapp, Co-CEO of Adimune™, to Discuss Progress of Lead Therapeutic Candidate ADI-100™ - businesswire.com
22 days ago - Dr. Charles Howe of the Mayo Clinic's Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt's Subsidiary Adimune™ - businesswire.com
23 days ago - Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - businesswire.com
25 days ago - Aditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis, and Stiff Person Syndrome Human Trials - businesswire.com
28 days ago - Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements - businesswire.com
30 days ago - Aditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing Requirements - businesswire.com
37 days ago - Appili President and CEO, Don Cilla Will Join Aditxt Co-founder and CEO, Amro Albanna, at the Aditxt Weekly Update on April 4, 2025 - businesswire.com
42 days ago - Upcoming Aditxt Weekly Update to Highlight Pearsanta's Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer Detection - businesswire.com
46 days ago - Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk - businesswire.com
53 days ago - Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025 - businesswire.com

Add to Watchlist

✕

Sections

Stocks
IPOs
ETFs
Blog

Services

Pricing Plan
Free Newsletter
Get Support

Website

Login
FAQ
Sitemap
Learning Center

Company

About
Contact Us
Terms of Use
Privacy Policy
Data Disclaimer
Affiliate Program

© 2025 Stocknear. All rights reserved.